Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early microscopic findings in preclinical inflammatory bowel disease.
Rodríguez-Lago I, Ramírez C, Merino O, Azagra I, Maiz A, Zapata E, Higuera R, Montalvo I, Fernández-Calderón M, Arreba P, Carrascosa J, Iriarte A, Muñoz-Navas M, Cabriada JL, Barreiro-de Acosta M. Rodríguez-Lago I, et al. Among authors: higuera r. Dig Liver Dis. 2020 Dec;52(12):1467-1472. doi: 10.1016/j.dld.2020.05.052. Epub 2020 Jun 26. Dig Liver Dis. 2020. PMID: 32601034
Characteristics and Progression of Preclinical Inflammatory Bowel Disease.
Rodríguez-Lago I, Merino O, Azagra I, Maiz A, Zapata E, Higuera R, Montalvo I, Fernández-Calderón M, Arreba P, Carrascosa J, Iriarte A, Portillo I, Aguirre U, Barreiro-de Acosta M, Muñoz-Navas M, Cabriada JL. Rodríguez-Lago I, et al. Among authors: higuera r. Clin Gastroenterol Hepatol. 2018 Sep;16(9):1459-1466. doi: 10.1016/j.cgh.2017.11.006. Epub 2017 Nov 11. Clin Gastroenterol Hepatol. 2018. PMID: 29133254
Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors.
Muñoz-Villafranca C, Ortiz de Zarate J, Arreba P, Higuera R, Gómez L, Ibáñez S, Merino O, Muñagorri A, Ogueta M, Rodriguez C, Nantes O, Ramirez de la Piscina P, Rodríguez I, Bernal A, Arévalo J, Cabriada J. Muñoz-Villafranca C, et al. Among authors: higuera r. Dig Liver Dis. 2018 Aug;50(8):812-819. doi: 10.1016/j.dld.2018.03.007. Epub 2018 Mar 14. Dig Liver Dis. 2018. PMID: 29625907
Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis.
Taxonera C, Iborra M, Bosca-Watts MM, Rubio S, Nantes Ó, Higuera R, Bertoletti F, Martínez-Montiel P, Sierra-Ausin M, Manceñido N, Lázaro Pérez-Calle J, Algaba A, Olivares D, Alba C. Taxonera C, et al. Among authors: higuera r. Curr Med Res Opin. 2019 Jul;35(7):1297-1304. doi: 10.1080/03007995.2019.1579557. Epub 2019 Mar 13. Curr Med Res Opin. 2019. PMID: 30722703
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease.
Rodríguez-Lago I, Aguirre U, Ramírez de la Piscina P, Muñagorri A, Zapata E, Higuera R, Montalvo I, Iriarte A, Fernández-Calderón M, Arreba P, Carrascosa J, Cabriada JL, Barreiro-de Acosta M. Rodríguez-Lago I, et al. Among authors: higuera r. United European Gastroenterol J. 2023 Feb;11(1):9-18. doi: 10.1002/ueg2.12352. Epub 2022 Dec 22. United European Gastroenterol J. 2023. PMID: 36547009 Free PMC article.